| 1 (31) | Samsung Corp * | MUL |  |
| 2 (85) | MedImmune, LLC. | USA | |
| 3 (94) | Toyota Group * | MUL | |
| 4 (103) | F Hoffmann-La Roche * | MUL | |
| 5 (120) | Regeneron Pharmaceuticals Inc | USA | |
| 6 (126) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 7 (127) | IBM United States | USA | |
| 8 (128) | Hoffmann-La Roche Ltd, United States | USA | |
| 9 (134) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 10 (140) | Novartis Institutes for Biomedical Research, United States | USA | |
| 11 (141) | Genentech Inc | USA | |
| 12 (147) | AstraZeneca * | MUL | |
| 13 (161) | Bristol-Myers Squibb Company, United States | USA | |
| 14 (168) | Alphabet Inc * | MUL | |
| 15 (174) | Bristol-Myers Squibb Company * | MUL | |
| 16 (177) | GlaxoSmithKline * | MUL | |
| 17 (180) | Novartis * | MUL | |
| 18 (185) | Merck * | MUL | |
| 19 (186) | Sumitomo Group * | MUL | |
| 20 (187) | Biogen Idec, USA | USA | |
| 21 (192) | Siemens * | MUL | |
| 22 (201) | Biogen Idec * | MUL | |
| 23 (207) | Sanofi, United States | USA | |
| 24 (217) | Johnson & Johnson * | MUL | |
| 25 (219) | Merck & Co Inc, United States | USA | |
| 26 (220) | GlaxoSmithKline, United States | USA | |
| 27 (221) | AstraZeneca, United Kingdom | GBR | |
| 28 (222) | Sanofi * | MUL | |
| 29 (233) | Siemens AG, Germany | DEU | |
| 30 (236) | Pfizer * | MUL | |
| 30 (236) | IBM Research * | MUL | |
| 32 (239) | Pfizer Inc, United States | USA | |
| 33 (246) | Gilead Sciences Inc, United States | USA | |
| 34 (247) | Janssen | MUL | |
| 35 (248) | Gilead Sciences * | MUL | |
| 36 (254) | BMJ Group | GBR | |
| 37 (260) | General Electric Company * | MUL | |
| 37 (260) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 39 (265) | Hitachi * | MUL | |
| 40 (268) | Janssen Biotech Inc | USA | |
| 41 (273) | Amgen, USA | USA | |
| 42 (276) | Amgen * | MUL | |
| 43 (283) | Merck KGaA, Germany | DEU | |
| 44 (286) | Eli Lilly and Company, United States | USA | |
| 45 (289) | Boehringer Ingelheim * | MUL | |
| 46 (292) | AstraZeneca, United States | USA | |
| 47 (299) | Robert Bosch * | MUL | |
| 48 (302) | Novo Nordisk * | MUL | |
| 49 (303) | Eli Lilly * | MUL | |
| 50 (309) | GlaxoSmithKline, United Kingdom | GBR | |
| 51 (312) | Novo Nordisk A/S | DNK | |
| 52 (313) | Bayer * | MUL | |
| 53 (321) | Janssen Research & Development, LLC | BEL | |
| 54 (325) | Boehringer Ingelheim, USA | USA | |
| 55 (332) | Boehringer Ingelheim GmbH Germany | DEU | |
| 56 (333) | Celgene Corp | USA | |
| 57 (335) | Koninklijke Philips NV * | MUL | |
| 58 (336) | Siemens AG, USA | USA | |
| 59 (338) | Bayer AG, Germany | DEU | |
| 60 (363) | AbbVie * | MUL | |
| 61 (364) | AbbVie Inc, United States | USA | |
| 62 (382) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 63 (392) | Philips Research, Eindhoven | NLD | |
| 64 (399) | Takeda Pharmaceuticals International Inc * | MUL | |
| 65 (406) | Novartis, Switzerland | CHE | |
| 65 (406) | VTT Technical Research Centre of Finland | FIN | |
| 67 (427) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 68 (434) | Danone * | MUL | |
| 69 (439) | UCB Pharma SA * | MUL | |
| 70 (440) | DowDupont * | MUL | |
| 71 (441) | AstraZeneca, Sweden | SWE | |
| 72 (442) | GlaxoSmithKline, Belgium | BEL | |
| 73 (443) | Shionogi & Co Ltd | JPN | |
| 74 (451) | Danone Nederland BV | NLD | |
| 75 (453) | BASF Group * | MUL | |
| 76 (456) | BASF, Germany | DEU | |
| 77 (457) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 78 (458) | Siemens Healthineers, USA | USA | |
| 79 (465) | Novartis Pharmaceuticals, United States | USA | |
| 80 (469) | GE Healthcare | MUL | |
| 81 (470) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 82 (472) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 83 (480) | Syngenta * | MUL | |
| 84 (494) | Nestle Switzerland | CHE | |
| 85 (495) | Medtronic * | MUL | |
| 86 (500) | Translational Research Institute | AUS | |
| 87 (501) | Nestle * | MUL | |
| 87 (501) | Bayer Corp, USA | USA | |
| 89 (520) | Pfizer Inc, United Kingdom | GBR | |
| 90 (531) | UCB Pharma SA, Brussels | BEL | |
| 91 (537) | Unilever * | MUL | |
| 92 (539) | Lockheed Martin Corp * | USA | |
| 93 (555) | SINTEF Group | NOR | |
| 94 (557) | Astellas Pharma Inc | JPN | |
| 95 (560) | GeneDx | USA | |
| 96 (572) | Allergan plc * | MUL | |
| 96 (572) | Allergan plc, USA | USA | |
| 98 (597) | Eli Lilly and Company Ltd., United Kingdom | GBR | |
| 99 (606) | Springer Nature, New Zealand | NZL | |
| 99 (606) | Springer Nature * | MUL | |
| 101 (618) | RTI Health Solutions | USA | |
| 102 (620) | Johnson & Johnson, United States | USA | |
| 103 (630) | IMEC International | BEL | |
| 104 (643) | Abbott Laboratories * | MUL | |
| 105 (652) | Manipal Global Education Group * | MUL | |
| 106 (656) | EMMES Corp | USA | |
| 107 (658) | Nippon Telegraph and Telephone Corp, Japan | JPN | |
| 108 (701) | Elsevier, France | FRA | |
| 109 (723) | ARUP Laboratories | USA | |
| 110 (736) | Pharmaceutical Product Development LLC | USA | |
| 111 (768) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 112 (817) | GE Healthcare China Co Ltd | CHN | |
| 113 (854) | Estacio Participacoes SA * | BRA | |
| 114 (916) | RELX Group plc * | MUL | |
|
